SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disordersJosé Luís Piñana, David Navarro, Lucía López‐Corral et al.|Journal of Hematology & Oncology|2022Cited by 39
Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem?Juan Luis Steegmann, Ferran Vall‐Llovera, Valentín García‐Gutiérrez et al.|Annals of Hematology|2018Cited by 26
Voriconazole Prophylaxis in Children With CancerGabriela Marón, Katherine M. Knapp, Randall T. Hayden et al.|The Pediatric Infectious Disease Journal|2013Cited by 25